Funda Şimşek, The Study Group for Viral Hepatitis of the Turkish Society of Clinical Microbiology and Infectious Diseases*, Gökmen Zararsız, Faruk Karakeçili, Sami Kınıklı, Hüseyin Bilgin, et al. Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience. Turkish Journal of Gastroenterology [Internet]. 2020 May 7 [cited 2025 Jul. 16];31(4):305-17. Available from: https://tjg.avesjournals.com/index.php/tjg/article/view/3881